Breast cancer patients with high expression of NOTCH3 tended to have long DRFS (p = 0.236, HR = 0.583) (Figure 6G), while high ZEB1 levels predicted poor DRFS in patients with breast cancer (p = 0.0151, HR = 2.59) (Figure 6H). Here, ZEB1 is linked to breast cancer.